Your browser doesn't support javascript.
loading
A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery.
Vargas, Servando Hernandez; Lin, Christie; AghaAmiri, Solmaz; Voss, Julie; Ikoma, Naruhiko; Tran Cao, Hop S; Ghosh, Sukhen C; Uselmann, Adam J; Azhdarinia, Ali.
Affiliation
  • Vargas SH; Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (Houston, TX, USA).
  • Lin C; OnLume, Inc. (Madison, WI, USA).
  • AghaAmiri S; Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (Houston, TX, USA).
  • Voss J; Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (Houston, TX, USA).
  • Ikoma N; University of Texas MD Anderson Cancer Center (Houston, TX, USA).
  • Tran Cao HS; University of Texas MD Anderson Cancer Center (Houston, TX, USA).
  • Ghosh SC; Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (Houston, TX, USA).
  • Uselmann AJ; OnLume, Inc. (Madison, WI, USA).
  • Azhdarinia A; Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (Houston, TX, USA).
Proc SPIE Int Soc Opt Eng ; 112222020.
Article in En | MEDLINE | ID: mdl-34054189
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Proc SPIE Int Soc Opt Eng Year: 2020 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Proc SPIE Int Soc Opt Eng Year: 2020 Document type: Article Country of publication: United States